Ursodeoxycholic Acid Induced Generalized Fixed Drug Eruption
| dc.authorscopusid | 54179576500 | |
| dc.authorscopusid | 8941649100 | |
| dc.authorscopusid | 36476941100 | |
| dc.authorscopusid | 26646261000 | |
| dc.contributor.author | Ozkol, Hatice Uce | |
| dc.contributor.author | Calka, Omer | |
| dc.contributor.author | Dulger, Ahmet Cumhur | |
| dc.contributor.author | Bulut, Gulay | |
| dc.date.accessioned | 2025-05-10T17:42:45Z | |
| dc.date.available | 2025-05-10T17:42:45Z | |
| dc.date.issued | 2014 | |
| dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
| dc.department-temp | [Ozkol, Hatice Uce; Calka, Omer] Yuzuncu Yil Univ, Dept Dermatol, Fac Med, Van, Turkey; [Dulger, Ahmet Cumhur] Yuzuncu Yil Univ, Dept Gastroenterol, Fac Med, Van, Turkey; [Bulut, Gulay] Yuzuncu Yil Univ, Dept Pathol, Fac Med, Van, Turkey | en_US |
| dc.description.abstract | Fixed drug eruption (FDE) is a rare form of drug allergies that recur at the same cutaneous or mucosal site in every usage of drug. Single or multiple round, sharply demarcated and dusky red plaques appear soon after drug exposure. Ursodeoxycholic acid (UDCA: 3 alpha,7 beta-dihydroxy-5 beta-cholanic acid) is used for the treatment of cholestatic liver diseases. Some side effects may be observed, such as diarrhea, dyspepsia, pruritus and headaches. We encountered only three cases of lichenoid reaction regarding the use of UDCA among previous studies. In this article, we reported a generalized FDE case related to UDCA intake in a 59-year-old male patient with cholestasis for the first time in the literature. | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded | |
| dc.identifier.doi | 10.3109/15569527.2013.838253 | |
| dc.identifier.endpage | 258 | en_US |
| dc.identifier.issn | 1556-9527 | |
| dc.identifier.issn | 1556-9535 | |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.pmid | 24147950 | |
| dc.identifier.scopus | 2-s2.0-84906654575 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 256 | en_US |
| dc.identifier.uri | https://doi.org/10.3109/15569527.2013.838253 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14720/15658 | |
| dc.identifier.volume | 33 | en_US |
| dc.identifier.wos | WOS:000341288800018 | |
| dc.identifier.wosquality | Q4 | |
| dc.language.iso | en | en_US |
| dc.publisher | informa Healthcare | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Bile Acids | en_US |
| dc.subject | Generalized Fixed Drug Eruption | en_US |
| dc.subject | Ursodeoxycholic Acid | en_US |
| dc.title | Ursodeoxycholic Acid Induced Generalized Fixed Drug Eruption | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |